S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
OTCMKTS:JSCPF

JSR (JSCPF) Stock Price, News & Analysis

$27.02
0.00 (0.00%)
(As of 12/5/2023)
Today's Range
$27.02
$27.02
50-Day Range
$27.02
$27.02
52-Week Range
$27.02
$27.02
Volume
100 shs
Average Volume
400 shs
Market Capitalization
N/A
P/E Ratio
0.25
Dividend Yield
114.94%
Price Target
N/A
JSCPF stock logo

About JSR Stock (OTCMKTS:JSCPF)

JSR Corporation engages in the plastics, digital solutions, and life sciences businesses in Japan and internationally. Its Digital Solutions Business provides lithography, photoresists, multi layered, packaging, cleaning, CMP materials, etc.; colour liquid crystal display, organic electroluminescence display materials, etc.; and heat-resistant transparent resin, functional films, and stereolithography, etc. The company's Life Sciences Business offers services to support drug development, vitro reagents for diagnostics, research and raw materials for regent, bioprocess materials, etc. Its Plastics Business provides synthetic resins, including ABS, AES, AS, and ASA resins. The company's Other Business offers acrylic emulsion, water-based emulsion, and stain resistance. JSR Corporation was incorporated in 1948 and is headquartered in Tokyo, Japan.

JSCPF Stock Price History

JSCPF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive JSCPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JSR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:JSCPF
Fax
N/A
Employees
7,994
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Eric R. Johnson (Age 63)
    Representative Director, President & CEO
    Comp: $1.42M
  • Mr. Nobuo Kawahashi (Age 68)
    Executive Advisor
    Comp: $613.99k
  • Mr. Kenichi Emoto (Age 51)
    Senior Executive Officer of Accounting, Finance, Corporate Communications & Director
  • Motoyuki Shima
    Dep, R&D, Dep. CTO, Director of Yokkaichi Research Center & Precision Electronics Research Institute
  • Makoto Doi
    Managing Officer of Legal Affairs & Compliance
  • Mr. Kazumasa Yamawaki
    Senior Officer of Plastics Business & Deputy GM of Elastomer Division
  • Mr. Seiji Takahashi (Age 61)
    Managing Officer of Mfg., Proc., Log., Env., Safety & Qlt. Ass., Yokkaichi Plt. Mgr. and Director
  • Mikio Yamachika
    Senior Officer of Supervising Digital Solutions Business, Manufacturing & Technology
  • Mr. Tim Lowery
    Senior Officer of Life Sciences Business & GM of Life Sciences Div.
  • Mr. Koichi Hara (Age 54)
    Managing Officer of Corporate Planning & M&A and Representative Director

JSCPF Stock Analysis - Frequently Asked Questions

How have JSCPF shares performed in 2024?

JSR's stock was trading at $27.02 at the start of the year. Since then, JSCPF shares have increased by 0.0% and is now trading at $27.02.
View the best growth stocks for 2024 here
.

Are investors shorting JSR?

JSR saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 247,400 shares, an increase of 15.0% from the February 29th total of 215,200 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.
View JSR's Short Interest
.

Is JSR a good dividend stock?

JSR (OTCMKTS:JSCPF) pays an annual dividend of $31.06 per share and currently has a dividend yield of 1.63%. The dividend payout ratio is 29.28%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of JSR?

Shares of JSCPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:JSCPF) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners